Similarly, the RNA‐seq data (GSE130970 and GSE126848) from the GEO database confirmed that the transcript levels of SAMM50 were higher in NAFLD patients (Fig. 1C). This evidence concerns the gene SAMM50 and metabolic dysfunction-associated steatotic liver disease.